Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Track changes in personal budgets to understand drivers, uncover trends, and refine spending and saving habits.
22,888 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
In a high-stakes wager, crypto veteran Arthur Hayes argues that AI-fueled liquidity rescue could catapult Bitcoin tow...
A high pre-tax withdrawal can push Social Security into higher taxation, prolonging Medicare costs and altering retir...
A block production hiccup temporarily paused Base, the Coinbase-backed layer-2 on Ethereum. This article breaks down ...
Bright MLS will begin feeding its broker listings into Google search results via HouseCanary ComeHome, expanding how ...
Retirees face a stubborn reality: utility bills keep arriving. A disciplined mix of dividend growth stocks, inflation...
As India intensifies crypto oversight, the local premium for USDT widens to 8.5%, forcing rupee buyers into costlier ...
Fresh data show XRP whales dispersing their flow beyond Binance, with large transfers gaining share across centralize...
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
Nvidia stands at a crossroads: rising Chinese demand for AI GPUs could lift sales, but policy risks and fierce compet...
Morgan Stanley just boosted its payout while re-upping a massive buyback. This article breaks down what the paired di...
Bitwise’s Matt Hougan argues that Strategy’s role as Bitcoin’s dominant corporate buyer is shifting as institutions s...